603998 Hunan Fangsheng Pharmaceutical
- 12.06
- -0.03-0.25%
Hunan Fangsheng Pharmaceutical News
Fangsheng Pharmaceutical 2024 Semi-Annual Equity Distribution Implementation Notice
Fangsheng Pharmaceutical\'s progress announcement on the transfer of part of the holding subsidiary\'s shares and the introduction of strategic investors
Fangsheng Pharmaceutical\'s progress announcement on the transfer of part of the holding subsidiary\'s shares and the introduction of strategic investors
Fangsheng Pharmaceutical\'s announcement on the 2024 semi-annual profit distribution plan
Legal Opinion of Guangdong Huashang (Changsha) Law Firm on the Implementation of Partial Restricted Stock Buyback and Cancellation of Hunan Fangsheng Pharmaceutical Co., Ltd.'s 2022 Stock-Based Incentive Plan
Hunan Fangsheng Pharmaceutical's announcement regarding the implementation of restricted share buyback and cancellation concerning stock-based incentives
Announcement of Shareholding Reduction by Shareholders of Hunan Fangsheng Pharmaceutical.
Legal Opinion of Guangdong Huashang (Changsha) Law Firm on the unlocking of the first restricted stocks awarded under the Hunan Fangsheng Pharmaceutical Co., Ltd. 2022 Restricted Stock Incentive Plan and its listing.
Announcement of the first unlocking of restricted stocks under the 2022 Restricted Stock Incentive Plan and listing by Hunan Fangsheng Pharmaceutical.
Announcement of Hunan Fangsheng Pharmaceutical regarding a 1% change in shareholder equity.
Hunan Fangsheng Pharmaceutical's notice regarding repurchasing and cancelling restricted stocks subject to buyback restrictions, as announced to creditors.
Announcement of Hunan Fangsheng Pharmaceutical regarding the adjustment of the restricted share buyback price and the cancellation of repurchased and un-released restricted stocks of incentive objects.
Legal Opinion of Guangdong Huashang (Changsha) Law Firm on the Adjustment of Repurchase Price and Cancellation of Restricted Stocks of Hunan Fangsheng Pharmaceutical Co., Ltd.'s 2022 Restricted Stock Incentive Plan
Announcement on the Progress of Transfer of Equity of Hunan Fangsheng Pharmaceutical's Controlling Subsidiary and Introduction of Strategic Investors.
Announcement of the implementation result of Hunan Fangsheng Pharmaceutical's senior management shareholding plan.
Hunan Fangsheng Pharmaceutical's 2023 Annual Equity Distribution Implementation Announcement.
Fangsheng Pharmaceutical Shareholders' Shareholders' Share Reduction Plan Announcement
Fangsheng Pharmaceutical's progress announcement on the transfer of part of the holding subsidiary's shares and the introduction of strategic investors
Fangsheng Pharmaceutical's Implementation Notice on Equity Incentive Restricted Stock Repurchase and Cancellation
Legal opinion of Guangdong Huashang (Changsha) Law Firm on matters relating to the implementation of partial restricted stock repurchase and cancellation of the 2022 equity incentive plan of Hunan Nansheng Pharmaceutical Co., Ltd.
Analysis
Price Target
No Data
No Data